About 40-50,000 patients receive GLP-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors(SGLT-2i) drugs, 84,000 were treated with dipeptidyl peptidase-4 (DPP-4) and more than 200,000 received sulfonylureas, with tracking of major adverse outcomes of all-cause mortality, heart attack, stroke, need for coronary revascularization
That is a win for employers, insurers, and the healthcare system as a whole
L.AgerholmM.FarupJ.DalbramE.NielsenJ.rtenbladN.et al (2021)
Its also important that we emphasize to patients that these drugs are to be used in combination with healthy lifestyle choices, not alone
Formula: C 10 H 12 D 5 N 3 O 6 S Molecular Weight:312.35 Storage: Please store the product under the recommended conditions in the Certificate of Analysis